share_log

8-K: Current report

8-K: Current report

8-K：重大事件
美股SEC公告 ·  2024/11/19 05:35

Moomoo AI 已提取核心信息

On November 15, 2024, Cardio Diagnostics Holdings, Inc. conducted its annual meeting of stockholders, with approximately 55.51% of eligible shares represented. During the meeting, stockholders voted on four key proposals. The first proposal resulted in the election of seven directors to the board, with Meeshanthini Dogan, Ph.D., and other nominees receiving a majority of the votes. The second proposal, which was approved, allows the Board of Directors to effect a reverse stock split at their discretion within a year. The third proposal, also approved, permits the future issuance of shares amounting to 20% or more of the outstanding Common Stock in non-public transactions, as per Nasdaq rules. Lastly, the ratification of Prager Metis CPA’s LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was confirmed. The meeting's outcomes are detailed in the company's definitive proxy statement filed on October 4, 2024.
On November 15, 2024, Cardio Diagnostics Holdings, Inc. conducted its annual meeting of stockholders, with approximately 55.51% of eligible shares represented. During the meeting, stockholders voted on four key proposals. The first proposal resulted in the election of seven directors to the board, with Meeshanthini Dogan, Ph.D., and other nominees receiving a majority of the votes. The second proposal, which was approved, allows the Board of Directors to effect a reverse stock split at their discretion within a year. The third proposal, also approved, permits the future issuance of shares amounting to 20% or more of the outstanding Common Stock in non-public transactions, as per Nasdaq rules. Lastly, the ratification of Prager Metis CPA’s LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2024, was confirmed. The meeting's outcomes are detailed in the company's definitive proxy statement filed on October 4, 2024.
2024年11月15日，Cardio Diagnostics Holdings, Inc.召开了年度股东大会，约有55.51%的符合资格的股份参与。会议中，股东对四项关键提案进行了投票。第一项提案是选举七名董事进入董事会，Meeshanthini Dogan博士及其他提名人获得了多数票。第二项提案获得通过，允许董事会在一年内自行决定进行反向股票拆分。第三项提案也获得批准，允许未来按照纳斯达克规则在非公开交易中发行超过20%或更多的流通普通股。最后，对Prager Metis CPA’s LLC作为2024财年截至2024年12月31日的独立注册公共会计师事务所的确认也得到了批准。会议结果的详细信息在公司于2024年10月4日提交的最终委托书声明中列出。
2024年11月15日，Cardio Diagnostics Holdings, Inc.召开了年度股东大会，约有55.51%的符合资格的股份参与。会议中，股东对四项关键提案进行了投票。第一项提案是选举七名董事进入董事会，Meeshanthini Dogan博士及其他提名人获得了多数票。第二项提案获得通过，允许董事会在一年内自行决定进行反向股票拆分。第三项提案也获得批准，允许未来按照纳斯达克规则在非公开交易中发行超过20%或更多的流通普通股。最后，对Prager Metis CPA’s LLC作为2024财年截至2024年12月31日的独立注册公共会计师事务所的确认也得到了批准。会议结果的详细信息在公司于2024年10月4日提交的最终委托书声明中列出。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间